| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 海利尔药业集团股份有限公司（以下简称海利尔）始创于1999年，属国家定点农药与肥料生产企业，是一家集农药、中间体与功能性肥料研发、生产、销售、技术服务于一体的专业化、全球化大型农化集团，于2017年1月12日在上海证券交易所主板A股上市，股票代码603639，2022年实现营业收入45.35亿元。 海利尔现有员工3200余人，拥有世界级规模的烟碱类、甲氧基丙烯酸酯类农药生产基地，下辖青岛海利尔生物、青岛奥迪斯生物、青岛凯源祥化工、山东海利尔化工、青岛恒宁生物5大生产基地，通过良好的运营管理，达到原药4万吨、制剂7.5万吨的生产能力，持续稳定的为全球合作伙伴提供优质产品及服务。 海利尔以持续创新作为核心竞争力，先后被认定为国家级高新技术企业、国家火炬计划重点高新技术企业和国家创新型试点企业，拥有国家级企业技术中心、农业部农药研发重点实验室、博士后科研工作站、国家地方联建海洋生物源农药与环境友好型制剂工程研究中心4个国家级创新平台，拥有发明专利110余项，技术创新实力行业领先。 海利尔坚持“安全是天，环保是地，质量是命，人才是根”的生存理念，不忘初心，匠心耕耘，坚持“原药制剂一体化、国内国际一体化“的双轮驱动战略，不断开拓国内外市场，国内业务范围覆盖全国，海利尔国际业务拓展至80多个国家和地区，国际业务正助力海利尔走上发展快车道。 海利尔作为中国农药工业协会副会长单位、中国农药发展与应用协会副会长单位、中国农业技术推广协会副会长单位，将不负众望，肩负促进行业发展的历史使命，始终致力于以专业的技术服务、优质的产品、丰富的产业链资源，帮助种植者实现增产增收，携手广大业务合作伙伴共创共赢！ | ||||||||||||||||||||||||
| Main Business | 农药制剂、农药中间体、农药原药和水溶性肥料的研发、生产和销售。 | ||||||||||||||||||||||||
| Legal Representative | 葛家成 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 迟明明 | ||||||||||||||||||||||||
| Solicitors | 北京市金杜律师事务所 | ||||||||||||||||||||||||
| Auditors | 中兴华会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0532-58659169 | ||||||||||||||||||||||||
| Fax No | 0532-58659169 | ||||||||||||||||||||||||
| Website | www.hailir.cn | ||||||||||||||||||||||||
| hailir@hailir.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 12/01/2017 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 1.390 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.500 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 9.941 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 4.809B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |